Production is streamlined in our state-of-the-art facilities

Manufacturing

cGMP Sterile Manufacturing Facility I

Our current cGMP sterile manufacturing facility is dedicated to the production of complex injectable products, like liposomes, suspensions, Long-Acting Injectable products (LAIs), etc.

  • Fully isolator-based and automatic solution-filling line for vials

  • Lyophilization machines equipped with vial auto-loading and auto-unloading

  • Dedicated suite for manufacturing of cytotoxic products

  • Complies with both US and EU cGMP standards 

  • Successfully completed FDA PAI inspection in 2023

  • In-house cGMP QC lab and microbiology lab

  • On-site inspection, labeling, serialization, and aggregation

  • On-site cGMP warehouse

Under Construction: cGMP Sterile Manufacturing Facility II

Our second manufacturing facility will be constructed and also used for manufacturing complex injectable products, with a greater focus on Long-Acting Injectable products (LAIs). The facility will feature a state-of-the-art fully isolator-based automatic filling line.

Discover More